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Abstract
Objective: This study evaluated in vitro maturation (IVM) of oocytes in the germinal vesi-
cle (GV) stage in stimulated intracytoplasmic sperm injection (ICSI) cycles.
Materials and Methods: A total of 26 women, aged 18 -37 years, who were candidates 
for ICSI at the Fatemeh Zahra Infertility and Health Reproductive Research Center in 2007 
were recruited for this study. We used the standard long protocol for ovarian stimulation. 
Follicles >11 mm were punctured 36-38 hours after administration of 10000 IU human 
chorionic gonadotrophin (hCG). Immature oocytes were cultured for 24-30 hours. Oocytes 
that liberated polar bodies were injected by sperm prepared within the previous day. IVM 
fertilized oocytes were cultured an additional 24-30 hours for cleavage. The rates of matu-
ration, fertilization and cleavage in IVM oocytes were recorded and statistically compared 
to in vivo matured sibling oocytes.
Results: There were 279 collected oocytes (mean±SD: 10.73 ± 6.2), of which 4.08±2.79 
were subjected to IVM. An average of 2.73 ± 2.15 GV oocytes (70%) developed to met-
aphase II (MII). Although the maturation rate significantly differed between the IVM and in 
vivo MII sibling oocyte groups (p=0.027), the numbers of fertilized oocytes (p=0.795) and 
cleaved embryos (p=0.529) were not significantly high in the in vivo group. Transfer of IVM 
embryos occurred in only three cases with one pregnancy that resulted in the delivery of 
a healthy baby. 
Conclusion: This study shows that culturing GV oocytes can produce acceptable num-
bers of four-cell embryos on the transfer day. The developmental competence of oocytes 
is not significantly different between early stage IVM and in vivo sibling embryos.
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Introduction
Use of external gonadotrophins increases the num-
bers of harvested oocytes and enhances the preg-
nancy rate in assisted reproductive technology 
(ART). Nevertheless, about 15-20% of collected 
oocytes are immature and, in some cases, germinal 
vesicle (GV) oocytes may comprise a larger part 
of retrieved oocytes (1). Extensive studies have 
been performed on in vitro maturation (IVM) of 
immature oocytes in stimulated or unstimulated 
cycles (2-4). In unstimulated cycles there is no ex-
ternal gonadotrophin administration, which might 
be beneficial for avoiding ovarian hyperstimula-
tion syndrome (OHSS). Chian et al. have reported 
significant improvements in IVM rate by human 
chorionic gonadotrophin (hCG) priming before 
the retrieval of immature oocytes from polycystic 
ovarian syndrome (PCOS) patients (5). According 
to their study, 78.2% of immature oocytes ma-
tured to metaphase II (MII). In order to achieve an 
adequate number of oocytes, the use of gonado-
trophins is routine in stimulated intracytoplasmic 
sperm injection (ICSI) cycles. Retrieved cumulus-
oocyte complexes are denuded to access nuclear 
maturation and possible subsequent injection. 
Oocytes with GV or those lacking polar bodies 
undergo further culturing to attain matured MII 
oocytes. However, the efficacy of in vitro matured 
GV and MI oocytes for clinical use is questionable 
(1). There are reports of approximately 25% mei-
otic abnormalities in GV immature oocytes with 
an IVM rate of 42.9% (6). Despite the possibility 
that IVM oocytes would not have developmental 
competence as expected with in vivo oocytes, im-
mature oocytes may provide an opportunity for 
patients with inadequately matured oocytes or 
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those lacking oocytes on the puncture day. Is there 
a chance for embryo transfer using these immature 
oocytes? To answer this question we cultured GV 
oocytes for 24-30 hours and evaluated the rates of 
maturation, fertilization and cleavage in compari-
son with in vivo matured sibling oocytes from the 
same cycles.
Materials and Methods
This clinical study was carried out in the Fatemeh 
Zahra Infertility and Health Reproductive Re-
search Center from April 2006 until March 2007. 
The Center’s Ethical Committee approved the 
study. In total, 26 women aged 18-37 years with 
at least two collected GV oocytes on the puncture 
day were included in this study. There were no 
other excluding factors. Patients were given full 
information about the study and signed informed 
consents.
All patients underwent the standard long proto-
col of pituitary suppression with gonadotrophin 
releasing hormone (GnRH). After 17 days of oral 
contraceptives, pre-treatment buserelin subcuta-
neous injections (Superfact; Hoechst, Germany) 
were administrated at daily doses of 0.5 cc until 
the initiation of human menopausal gonadotrophin 
(HMG; Pergonal; Serono, Italy) on the second or 
third day of the next cycle. On the day of HMG 
initiation, the dose of buserelin was modified to 
0.25 cc until the time of HCG injection. Patients 
received HMG at a daily dose of 150-300 IU for 
6-7 days, which was modified according to the 
response. Patients underwent transvaginal ul-
trasound. When the largest measured follicle(s) 
reached a maximum mean diameter of 18-19 
mm, 10000 IU HCG (Pregnyle, Darupakhsh, 
Iran) was administrated intramuscularly. Follicles 
larger than 11 mm were transvaginally punctured 
36-38 hours after HCG injection. The oocytes 
after a maximum of one hour incubation in 6% 
CO2 and 37°C (Binder, Germany) under mineral 
oil (Nidoil, Nidacone, Sweden) were denuded 
with 1% hyaluronidase enzyme (Sigma Aldrich 
Co., Germany) and a hand drawn glass pipette. 
With the use of an invert microscope (TE 300, 
Nikon) at ×200 magnification, GV oocytes were 
detected. Our criteria for selected GV oocytes 
were the presence of a prominent nucleus in a 
homogenous cytoplasm with any type of defect 
in the oocyte’s overall appearance. The selected 
GV oocytes were placed in a drop of 20-30 μl GΙ 
media (Vitrolife, Sweden) in separate dishes for 
24-30 hours. Oocytes with liberated polar bodies 
were injected by sperm that were provided dur-
ing the previous day. Injected IVM oocytes were 
assessed after 16-18 hours for the appearance of 
pronuclei based on our routine practice. Zygotes 
were cultured for an additional 24-30 hours. A 
maximum of three embryos at the four-cell stage 
were transferred to each patient. In only three 
cases, due to unavailable embryos, we used the 
IVM-produced embryos. 
Data that included the rates of maturation, fer-
tilization and cleavage of in vitro and in vivo 
matured oocytes were analyzed with SPSS ver-
sion 18 software. We used the Wilcoxon test 
to compare groups at the 0.05 level of signifi-
cance.
Results
A total of 279 oocytes were collected from 26 wom-
en who were ICSI candidates. The frequency of har-
vested oocytes ranged from 2-30. The mean ± SD of 
oocytes was 10.73 ± 6.2. Of these, 4.08 ± 2.79 (42%) 
were subjected to IVM (Table 1). In seven cases, 
GV oocytes included ≥50% of the collected oocytes, 
with two cases that did not have MII (Fig 1).
Table 1: Comparison of collected oocytes, fertilization and 
cleavage between in vitro and in vivo sibling matured oocytes
p valueIn vivo sibling 
oocytes
IVM oocytes
Mean ± SD (%)Mean ± SD (%)
-4.08 ± 2.79 
(0.42 ± 0.22)
Oocytes
0.027*6.65 ± 4.35 
(0.58 ± 0.22)
2.73±2.15 
(0.70 ± 0.34)
MII
0.7954.42 ± 3.28 
(0.65 ± 0.29)
1.69 ± 1.69 
(0.65 ± 0.42)
Zygotes (2PN)
0.5292.88 ± 1.9 
(0.74 ± 0.29)
1.19 ± 1.36 
(0.70 ± 0.38)
Four-cell
embryos
Statistical analysis with Wilcoxon test.
*p<0.05 is at the level of significance.
In eleven cases, all retrieved GV oocytes developed 
to the MII stage after 24-30 hours of incubation. An 
average of 2.73 ± 2.15 GV oocytes (~70%) devel-
oped to MII. The mean ± SD for in vivo MII sib-
ling oocytes was 6.65 ± 4.35 (Table 1). Comparison 
between means of percent (%) in IVM and in vivo 
sibling oocyte groups was significantly different 
(p=0.027, Fig 2). Fertilization occurred in 65% of 
IVM-MII oocytes with the same percent for in vivo 
MII sibling oocytes (Table 1, Fig 2). Overall cleaved 
embryos in the four-cell stage were 70% in the IVM 
group (average: 1.19). In the in vivo sibling group, 
74% of embryos were in the four-cell stage (aver-
age: 2.88). The differences between means of fer-
tilized oocytes and four-cell embryos in IVM and 
in vivo sibling oocyte groups were not significant 
(Table 1, Fig 2). 
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IVM four-cell embryos were transferred in only three 
patients, with one pregnancy that resulted in the de-
livery of a healthy baby.
Discussion
In this study, we evaluated the rates of maturation, 
fertilization and cleavage in IVM-GV oocytes 
with in vivo matured sibling oocytes collected dur-
ing the same cycles. It was expected that the cul-
ture of GV oocytes for 24-30 hours could provide 
more embryos for transfer, particularly in cases 
with few or no mature oocytes available on the 
puncture day. Successful pregnancies from such 
prolonged cultures have been reported (7-9).
The percent of GV oocytes in our study (42%) was 
comparable with a report by Reichman et al. (1) 
where 37.2% of collected oocytes were in the GV 
stage. In other studies, the percent of collected GV 
oocytes was lower than our study, which probably 
resulted from different study conditions (Table 2).
The majority of GV collected from stimulated ova-
ries liberate the first polar body (PB) spontaneous-
ly after a minimum of 22 hours (10). An optimal 
ICSI time after the first PB extrusion of oocytes 
has been proposed by Hyun et al. (11). According 
to their study, GV oocytes would need at least one 
hour to complete nuclear maturation after the first 
PB extrusion. 
The fertilization rate was 15.8% in oocytes in-
jected within one hour vs. 80% in those injected 
within one to two hours after the first PB extru-
sion (11). 
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Fig 1: Frequency of oocytes in study cases 
Fig 2: Comparison between means of percent (%) in IVM and in vivo sibling groups
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We cultured GV oocytes for 24-30 hours based on 
IVM studies (12). Our maturation rate of GV ap-
proximated the upper limit of retrieved oocytes re-
ported in stimulated cycles, which was 35%-78% 
(1, 3, 10, 13). The means of MII oocytes between 
the IVM and in vivo sibling oocytes were signifi-
cantly different in our study, which was similar to 
other researches (1, 10).
Fertilization rates in GV-matured and in vivo 
MII sibling oocytes were not significantly dif-
ferent in our study, which confirmed the report 
of Reichman and colleagues (62.1% vs. 64.0%, 
p=0.9909). Kim et al. studied two groups of GV 
oocytes with or without cumulus cells and report-
ed that the presence of cumulus cells did not sig-
nificantly change the proportion of GV oocytes 
that reached MII. Overall, the normal fertilization 
rate was 51.8% (13). In the reports of Escrich et 
al. (10) and Nagy et al. (7), the rates of fertiliza-
tion were 59.7% and 78%, respectively. In other 
studies the fertilization rates in the IVM and in 
vivo groups significantly differed, which was in 
contrast to our study (10, 13).
PB extrusion and activation of MII oocytes in 
the subsequent entrance of spermatozoa in fer-
tilization could be defined as oocyte compe-
tency. It has been reported that morphological 
and morphometric measures, and the chromatin 
condensation stage of GV oocytes were not pre-
dictors of nuclear and cytoplasmic competence 
(10). We selected GV oocytes with prominent 
nuclei in homogenous cytoplasm with any type 
of defect in overall appearance of oocyte. The 
maturation and fertilization rates in our study 
show that these simple, practical criteria might 
be enough to choose GV for an extended culture 
program.
In this study, the means of percent of cleaving 
embryos that reached the four-cell stage in the 
IVM group approximated the in vivo group, but 
was not significantly different (p=0.529). While 
it was reported that day two embryos had reduced 
quality and four-cell embryos were significant-
ly lower in the IVM group (28.3% vs. 54.3%, 
p=0.0026) (1), in a case report the cleavage rate 
was 71%, which resulted in a healthy baby (7). 
In another report, 84.5% of IVM cleaved em-
bryos reached the four-cell stage after 40 hours 
and was not significantly different from the in 
vivo group, as seen with our study. The cleavage 
rate of the IVM group in our study and Kim’s 
work did not significantly differ from the in vivo 
group in the four-cell stage (13). Additionally, 
Shu et al. reported after 4-6 hours of incubation, 
100% of injected eggs that did not mature at the 
time of denudation were cleaved (14).
A comparison between IVM of oocytes in stimu-
lated and unstimulated cycles reveals that without 
stimulation of gonadotrophins there is a reduction 
in collected oocytes and a subsequent decrease 
in cleavage and pregnancy rate. In fact, IVM is 
primarily used for women with PCO or PCOS to 
avoid OHSS. Regularly cycling women and over 
responders are other groups for HCG priming 
IVM (15). In PCOS patients there are significant 
variances in the reports of pregnancy and implan-
tation rates among studies (17%-52% pregnancy; 
6%-27% implantation) (15). In a recent study of 
34 IVM cycles in PCO and PCOS cases, oocyte 
maturation and fertilization rates have been re-
ported as 63% and 62%, respectively. The cleav-
age rate was 14.6% (all normal zygotes reached 
the two cell stage on day two) and only 9% day 
three embryos were of very good quality. The 
clinical gestation rate was 32%. Although the ma-
jority of the embryos (68%) were of a low quality, 
the pregnancy rate was comparable with classic 
stimulated cycles (16).
In another research on 63 regular cycles (568 
oocytes with an average of 9) maturation rate, fer-
tilization and cleavage rates were 74.3%, 72.6% 
and 89.0%, respectively (17).
IVM of GV Oocytes
Table 2: Outcome of IVM cycles from literature
Live
births
Clinical 
pregnancy 
rate/embryo 
transfer (%)
Cleavage 
rate (%)
Fertilization
rate (%)
In vitro
maturation
rate (%)
No. of GV
oocytes
Authors(year)
110071786414Nagy et al. (1996)
--84.551.866.7168Kim et al. (2000)
9 17.6 8972.674.3506Yoon et al. (2001)
-210044.237.5-Shu et al. (2007)
nonenone20.5 60.035.1-Reichman et al. 
(2010)
---59.774.8131Escrich et al. (2010)
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The experience of somatic cell nuclear transfer to 
the ooplasm of GV oocytes (haploidization) result-
ed in subsequent extrusion of the first PB in 39.1% 
of reconstructed oocytes. This practice revealed 
that ooplasms in the GV stage probably play an 
essential role in the liberation of the first PB and 
nuclear maturation (18).
The results of this study and other works have 
shown variations in the fertilization and cleavage 
rates of IVM and in vivo MII oocytes. Addition-
ally, the frequency of collected immature oocytes 
differs among studies. These dissimilarities might 
be due to the conditions under which studies have 
been performed. Several variables affect oocytes, 
therefore the variation between results is not un-
expected. However, it seems the most important 
question pertains to which situations immature 
GV oocytes must be cultured. Can GV oocytes be 
ignored when there are few or no MII oocytes on 
the puncture day? Although cytoplasmic compe-
tency has been shown to be compromised in pre-
vious works, nuclear maturation in GV oocytes is 
a universal concept. According to our results and 
others, culturing GV oocytes should be performed 
in cases of few MII in vivo oocytes or in patients 
whose numbers of GV oocytes with respect to 
MII are high. There is no need to culture GV 
oocytes when there are enough mature oocytes on 
the puncture day.
Conclusion 
This study showed that prolonged culture of GV 
oocytes produced acceptable numbers of four-cell 
embryos on day two transfers. The developmental 
competence of GV-IVM oocytes were only defined 
in the early stage and did not significantly differ 
when compared with in vivo sibling oocytes. 
Acknowledgments 
The authors express thei  appreciation to the Re-
search Deputy of Babol University for financial 
support. We especially thank Dr Sorya Khafri for 
her assistance with statistical analysis, and Miss 
Fezzeh Hashemi, Mrs. Fatemeh Nadi Heidari and 
Mrs. Maedeh Fassihian, in addition to the staff of 
Fatemeh Zahra Infertility and Health Reproductive 
Research Center. There is no conflict of interest in 
this article.
References
Reichman DE, Politch J, Ginsburg ES, Racowsky 1. 
C. Extended in vitro maturation of immature oocytes 
from stimulated cycles: an analysis of fertilization 
potential, embryo development, and reproductive 
outcomes. J Assist Reprod Genet. 2010; 27(7): 347-
356.
Cha KY, Chian RC. Maturation in vitro of immature 2. 
human oocytes for clinical use. Hum Reprod Up-
date. 1998; 4(2):103-120. 
Chian RC, Tan SL. Maturational and developmen-3. 
tal competence of cumulus-free immature human 
oocytes derived from stimulated and intracytoplas-
mic sperm injection cycles. Reprod Biomed Online. 
2002; 5(2):125-132.
Trounson A, Wood C and Kausche A. In vitro matu-4. 
ration and the fertilization and developmental com-
petence of oocytes recovered from untreated poly-
cystic ovarian patients. Fertil Steril. 1994; 62(2): 
353-362.
Chian RC, Buckett WM, Tulandi T, Tan SL. Prospec-5. 
tive randomized study of human chorionic gonado-
trophin priming before immature oocyte retrieval 
from unstimulated women with polycystic ovarian 
syndrome. Hum Reprod. 2000; 15(1): 165-170.
Vieira RC, Barcelos ID, Ferreira EM, Martins 6. 
WP,Ferriani RA, Navarro PA. Spindle and chromo-
some configurations of in vitro-matured oocytes 
from polycystic ovary syndrome and ovulatory in-
fertile women: a pilot study. J Assist Reprod Genet. 
2011; 28(1): 15-21.
Nagy ZP, Cecile J, Liu J, Loccufier A, Devroey P, 7. 
Van Steirteghem A . Pregnancy and birth after in-
tracytoplasmic sperm injection of in vitro matured 
germinal-vesicle stage oocytes: Case report. Fertil 
Steril. 1996; 65(5): 1047-1050.
Demirol A, Guven S, Benkhalifa M, Sari T, Gurgan T. 8. 
Successful birth following transfer of frozen-thawed 
embryos produced from in-vitro matured oocytes.
Reprod Biomed online. 2010; 21(2): 215-218.
Son WY, Lee SY, Chang MJ, Yoon SH, Chian RC, 9. 
Lim JH. Pregnancy resulting from transfer of repeat 
vitrified blastocysts produced by in-vitro matured 
oocytes in patient with polycystic ovary syndrome. 
Reprod Biomed online . 2005; 10(3): 398-401.
Escrich L, Grau N, Mercader A, Rubio C, Pellicer A, 10. 
Escribá MJ. Spontaneous in vitro maturation and ar-
tificial activation of human germinal vesicle oocytes 
recovered from stimulated cycles. J Assist Reprod 
Genet.2011;28(2): 111-117. 
Hyun CS, Cha JH, Son WY, Yoon SH, Kim KA, Lim 11. 
JH. Optimal ICSI timing after the first polar body 
extrusion in in vitro matured human oocytes. Hum 
Reprod. 2007; 22(7): 1991-1995.
Son WY, Yoon SH, Lim JH. Effect of gonadotrophin 12. 
priming on in-vitro maturation of oocytes collected 
from women at risk of OHSS. Reprod Biomed On-
line. 2006; 13(3): 340-348.
Kim BK, Lee SC, Kim KJ, Han CH, Kim JH. In vitro 13. 
maturation, fertilization, and development of human 
germinal vesicle oocytes collected from stimulated 
cycles. Fertil Steril. 2000; 74(6): 1153-1158.
Shu Y, Gebhardt J, Watt J, Lyon J, Dasig D, Behr B. 14. 
Fertilization, embryo development, and clinical out-
come of immature oocytes from stimulated intracy-
toplasmic sperm injection cycles. Fertil Steril. 2007; 
87 (5): 1022-1027.
Son WY, Tan SL. Laboratory and embryological as-15. 
pects of hCG-primed in vitro maturation cycles for 
patients with polycystic ovaries. Hum Reprod Up-
date. 2010; 16(6): 675-689.
Bos-Mikich A, Ferreira M, Höher M, Frantz G, Ol-16. 
iveira N, Dutra CG, et al. Fertilization outcome, em-
bryo development and birth after unstimulated IVM. 
J Assist Reprod Genet.2011; 28(2) : 107-110.
Farsi et al.
CELL JOURNAL(Yakhteh), Vol 13, No 2, Summer 2011         77
www.SID.ir
Ar
ch
ive
 of 
SID
Yoon HG, Yoon SH, Son WY, Lee SW, Park SP, 17. 
Im KS,et al. Pregnancies resulting from In Vitro 
Matured Oocytes collected from women with regu-
lar menstrual cycle. J Assist Reprod Genet. 2001; 
18(6): 325-329.
Palermo GD, Takeuchi T, Rosenwaks Z. Oocyte-18. 
induced haploidization. Reprod Biomed Online.on-
line. 2002; 4(3): 237-242.
IVM of GV Oocytes
CELL JOURNAL(Yakhteh), Vol 13, No 2, Summer 2011         78
www.SID.ir
